Lawsuit filed for Investors who lost money with shares of UnitedHealth Group Incorporated (NYSE: UNH)

An investor, who purchased shares of UnitedHealth Group Incorporated (NYSE: UNH), filed a lawsuit over alleged violations of Federal Securities Laws by UnitedHealth Group Incorporated in connection with certain allegedly false and misleading statements.

Investors who purchased shares of UnitedHealth Group Incorporated (NYSE: UNH) have certain options and for certain investors are short and strict deadlines running. Deadline: July 7, 2025. NYSE: UNH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Eden Prairie, MN based UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. UnitedHealth Group Incorporated (NYSE: UNH) reported that its annual Total Revenue rose from over $371.62 billion in 2023 to over $400.27 billion in 2024, and that its Net Income declined from $22.38 million in 2023 to $14.4 million in 2024.

On April 17, 2025, The Wall Street Journal published an article entitled "UnitedHealth Shares Tumble After Earnings Fall Short Due to Medicare Issues." The article stated that UnitedHealth stock fell after "earnings fell short of Wall Street's expectations, and the healthcare company substantially downgraded its projected results for 2025, citing problems in its Medicare business."

UnitedHealth Group Incorporated (NYSE: UNH) declined from $606.36 per share on April 11, 2025, to as low as $376.83 per share on May 12, 2025.

The plaintiff claims that between December 3, 2024 and April 16, 2025, the defendants made false and/or misleading statements and/or failed to disclose that UnitedHealth had, for years, engaged in a corporate strategy of denying health coverage in order to boost its profits, and ultimately, its share price, that this anti-consumer (and at times unlawful) strategy resulted in regulatory scrutiny (as well as public angst) against UnitedHealth, which ultimately resulted in the murder of Brian Thompson ("Thompson"), that animus towards UnitedHealth was such that, subsequent to the murder of Thompson, many Americans openly celebrated his demise, expressed admiration for his accused killer, and/or otherwise demanded that UnitedHealth change its strategy even if they condemned Thompson's killing, that the foregoing regulatory and public outrage caused UnitedHealth to change its corporate practices, that notwithstanding the foregoing, UnitedHealth recklessly stuck with the guidance it issued the day before Thompson's murder, which was unrealistic considering UnitedHealth's changing corporate strategies, and that as a result, defendants' public statements were materially false and/or misleading at all relevant times.

Those who purchased shares of UnitedHealth Group Incorporated (NYSE: UNH) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.